Other Stories

Full Video

Merck's COVID-19 pill shows significantly lower efficacy in updated study Updated: 2021-11-27 17:21:16 KST

An experimental COVID-19 treatment pill developed by Merck is significantly less effective than earlier data suggested.
The U.S. drugmaker said its oral pill showed a 30 percent reduction in deaths and hospitalizations based on its updated analysis while its previous data claimed a 50 percent reduction.
Merck released the data before the U.S. Food and Drug Administration published a set of documents on Friday.
And, the FDA's committee comprised of outside experts will meet on Tuesday to discuss whether to authorize the pill.
Merck's shares dropped by almost 3.8 percent on Friday.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.
weather